LEADOPTIK Announces FDA Clearance of the LIA(TM) for Lung Biopsy Procedures
LEADOPTIK, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Last Inch Assessment(TM) (LIA) system, the world's first system to use silicon photonics imaging technology and software designed to improve the accuracy of lung biopsy procedures. Lung cancer remains the leading cause of cancer-related death worldwide, claiming approximately 1.8 million lives […]